Mostrando 9 resultados de: 9
Publisher
Climacteric(2)
Maturitas(2)
Menopause(2)
American Journal of Obstetrics and Gynecology(1)
Gynecological Endocrinology(1)
Área temáticas
Salud y seguridad personal(7)
Farmacología y terapéutica(4)
Enfermedades(3)
Fisiología humana(3)
Cirugía y especialidades médicas afines(1)
Origen
scopus(9)
An individualized approach to the management of vaginal atrophy in Latin America
ReviewAbstract: Objective: In the absence of guidelines specific for Latin America, a region where the impact of menPalabras claves:genitourinary syndrome of menopause, Latin America, management, MENOPAUSE, Vaginal atrophy, vaginal healthAutores:Celis-González C., de Melo N.R., Fernandes C.E., Hernández-Bueno J.A., Kulak J., Luis Fernando Danckers, Mabel T. Martino, MacHado R.B., Nappi R.E., Palacios S., Pardini D., Pizzi R.R., Shapiro M., Storch E., Villaseca P., Wender M.C.O.Fuentes:scopusEMAS position statement: The ten point guide to the integral management of menopausal health
ArticleAbstract: With increased longevity and more women becoming centenarians, management of the menopause and postrPalabras claves:Hot Flushes, menopausal hormone therapy, MENOPAUSE, OSTEOPOROSIS, Postreproductive health, screeningAutores:Birkhauser M., Ceausu I., Depypere H., Erel T., Faustino R. Pérez-López, Lambrinoudaki I., Llaneza P., Neves-E-Castro M., Palacios S., Rees M., Samsioe G., Sánchez-Borrego R., Schenck-Gustafsson K., Simoncini T., Trémollieres F.A., van der Schouw Y.T.Fuentes:scopusEfficacy and safety of the aminobisphosphonate in the treatment of postmenopausal osteoporosis
ReviewAbstract: Aminobisphosphonates are a drug family widely used in the treatment of postmenopausal osteoporosis,Palabras claves:Alendronate, Aminobisphosphonates, Bisphosphonates, Efficacy, Frozen bone, OSTEOPOROSIS, safetyAutores:Faustino R. Pérez-López, Ferrer Barriendos J., Gómez De La Cámara A., Palacios S., Quereda Seguí F., Quesada Gómez M., Rodríguez Arboleya L., Vázquez Fernández F.Fuentes:scopusEfficacy of ossein-hydroxyapatite complex compared with calcium carbonate to prevent bone loss: A meta-analysis
ArticleAbstract: Objective: There is increasing evidence to suggest that ossein-hydroxyapatite complex (OHC) is morePalabras claves:bone mineral density, calcium carbonate, Meta-analysis, Ossein-hydroxyapatite complex, Osteoporosis preventionAutores:Blanch-Rubió J., Cancelo-Hidalgo M.J., Carbonell-Abelló J., Castelo-Branco C., Ciria-Recasens M., Haya-Palazuelos J., Ma José Martínez Zapata, Manasanch J., Palacios S., Pérez-Edo L.Fuentes:scopusIs fibromyalgia part of the climacteric syndrome?
ReviewAbstract: Fibromyalgia syndrome (FMS) is a disorder usually affecting middle aged women, who complain of diffuPalabras claves:Climacteric Symptoms, Fibromyalgia, MENOPAUSE, Middle aged womenAutores:J. E. Blümel, Legorreta D., Maríá Soledad Vallejo, Palacios S., Sarrá S.C.Fuentes:scopusVaginal Health: Insights, Views & Attitudes (VIVA-LATAM): results from a survey in Latin America
ArticleAbstract: Objective: To investigate awareness in Latin America, knowledge of postmenopausal vaginal atrophy waPalabras claves:attitude, genitourinary syndrome of menopause, Latin American women, local estrogen therapy, MENOPAUSE, Survey, Vaginal atrophy, vaginal healthAutores:Celis-González C., de Melo N.R., Mabel T. Martino, Nappi R.E., Palacios S., Röhrich S., Villaseca P.Fuentes:scopusVitamin D supplementation: position Statement of the Iberoamerican Society of Osteoporosis and Mineral Metabolism (SIBOMM)
ArticleAbstract: Background: Vitamin D (VD) deficiency is a global pandemic that affects more than a third of the popPalabras claves:Latin America, recommendations, supplementation, vitamin DAutores:Cerdas S., Córdoba S., Da Silva R., de Melo N.R., Luis Fernando Danckers, Maida T., Melo L., Moreno M., Mostajo D., Muñoz-Louis R., Navas M., Palacios S., Paradas A., Rasec-Morales L., Rosero O., Rueda C., Tserotas K., Vargas J., Vasquez D.Fuentes:scopusRaloxifene is not associated with biologically relevant changes in hot flushes in postmenopausal women for whom therapy is appropriate
ArticleAbstract: Objectives Raloxifene is approved for the treatment and prevention of postmenopausal osteoporosis. PPalabras claves:Hot Flushes, OSTEOPOROSIS, Postmenopausal women, Raloxifene, Selective estrogen receptor modulatorsAutores:Almeida M.J., Gustavo J. Gómez, Kayath M.J., Lucia F. Farias M., Luebbert H., Mönnig E., Nickelsen T., Palacios S., Quail D.C., Turbi C., Yabur J.A.Fuentes:scopusThe International Menopause Study of Climate, Altitude, Temperature (IMS-CAT) and vasomotor symptoms
ArticleAbstract: Objective To examine the relationship between climate (including altitude, temperature, humidity andPalabras claves:altitude, Climate, Hot Flushes, MENOPAUSE, TEMPERATURE, vasomotor symptomsAutores:Gupta P., Hunter M., J. E. Blümel, Palacios S., Peter A. Chedraui, Sturdee D., Tserotas K., Wéllington AguirreFuentes:scopus